MRNA
Moderna Inc
Biotechnology
Moderna Inc (MRNA) Financials
Annual revenue, profit, EPS and free cash flow for MRNA, pulled directly from its SEC 10-K filings — 2 fiscal years on record.
| Fiscal Year | Revenue | Gross Profit | Operating Income | Net Income | EPS (Diluted) | Free Cash Flow |
|---|---|---|---|---|---|---|
| FY2025 | $1.9B | — | $-3.1B | $-2.8B | -$7.26 | $-2.1B |
| FY2024 | $3.2B | — | $-3.9B | $-3.6B | -$9.28 | $-4.1B |
Figures as reported on SEC Form 10-K. Free cash flow is operating cash flow less capital expenditure.